lovastatin has been researched along with Mole, Skin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barr, RJ; Carpenter, PM; Chen, WP; Cochran, AJ; Elmets, CA; Jakowatz, JG; Leachman, SA; Lim, SJ; Linden, KG; McLaren, CE; Meyskens, FL; Tangrea, JA; Viner, JL; Zager, JS | 1 |
1 trial(s) available for lovastatin and Mole, Skin
Article | Year |
---|---|
A randomized, double-blind, placebo-controlled phase II clinical trial of lovastatin for various endpoints of melanoma pathobiology.
Topics: Adult; Anticholesteremic Agents; Biomarkers, Tumor; Cell Transformation, Neoplastic; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Lovastatin; Male; Melanoma; Middle Aged; Nevus; Placebos; Skin Neoplasms | 2014 |